Identifying high-risk patients, particularly those with reduced EF, high NT-proBNP, paroxysmal AF, and large interdialytic weight gains, may allow for personalized interventions, such as tighter volume control, rhythm management, or prioritization for transplantation. This evidence concerns the gene NPPB and Paroxysmal atrial fibrillation.